A Phase II Trial of PD-1 Knockout Engineered T Cells for the Treatment of Advanced Esophageal Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs PD-1 knockout T-cells (Primary) ; Cyclophosphamide; Interleukin-2
- Indications Oesophageal cancer
- Focus Adverse reactions
- 22 Mar 2017 New trial record
- 20 Mar 2017 Planned End Date changed from 30 Jun 2019 to 30 Dec 2018.
- 20 Mar 2017 Planned primary completion date changed from 30 Jun 2018 to 27 Feb 2018.